The development of oncofertility over the past decade has renewed the interest in in vitro
maturation (IVM) because of the specificity of some oncologic situations that may prevent the …

Oocyte in vitro maturation (IVM) is an assisted reproductive technology with a long and
sometimes checked history. It is a minimally invasive technique involving the deliberate …

This study tested in-vitro maturation (IVM) as a complementary strategy to improve the
mature oocyte yield of breast cancer patients undergoing ovarian stimulation for fertility …

In vitro maturation (IVM) of human immature oocytes has been shown to be a viable option
for patients at risk of ovarian hyperstimulation syndrome (OHSS), those seeking urgent …

Immature oocytes are an emerging source of gametes in patients with a diagnosis of cancer
who have not enough time to undergo stimulation of their ovaries to obtain mature oocytes …

In vitro maturation (IVM) of human immature oocytes has been offered to women who are at
risk of developing ovarian hyperstimulation syndrome (OHSS) caused by gonadotropin …

In vitro maturation (IVM) is an advanced embryology laboratory technique in which immature
oocytes, removed from ovarian follicles prior to completing their growth in vivo, are cultured …

To ensure patient care in an oncological fertility preservation (FP) programme, specialists
must provide technology that best suits the patients' clinical conditions. In vitro oocyte …

Oocyte in vitro maturation (IVM) is an assisted reproductive technology designed to obtain
mature oocytes following culture of immature cumulus–oocyte complexes collected from …

Although female cancer incidence may be on rise, antineoplastic regimens have become
more successful. As a result, an increasing number of women with cancer survive to endure …